Roy Elias
@rmelias2
Genitourinary oncologist @hopkinskimmel. RCC research and computational biology
ID: 1972687579
19-10-2013 19:49:01
76 Tweet
336 Followers
600 Following
Thank you Urology Times for the recent series of interviews highlighting our work on socioeconomic and racial disparities in #kidneycancer Lots of work to do to close the gap! Urologic Oncology The Johns Hopkins Brady Urological Institute Johns Hopkins Medicine Ridwan Alam Roy Elias
#KCRS24 Rapid Abstract: Roy Elias Johns Hopkins Kimmel Cancer Center explores brain-specific tumor evolution in metastatic RCC. Uncover genetic changes and immune suppression in brain metastases for new treatment insights! Abstract Book: bit.ly/KCRS24Abstracts Register: kcrs.kidneycan.org
Very interesting to see how this discussion has evolved over the past decade. I remember ~5y ago when the choice was largely between #CM214 & #KN426; at that time, the argument for #IMDC appeared to be much stronger, for good reason. Good to have Daniel Heng at #AUC3 to offer a
✋✋✋Who's joining us this afternoon to hear Sumanta K. Pal, MD, FASCO and Laurence Albiges review the latest #KidneyCancer research? If you can't join live at 1 pm ET, register to get the video delivered right to your inbox: bit.ly/KidneyCANTownH… 📢OncoAlert Toni Choueiri, MD Hans Hammers Rana McKay, MD, FASCO
We're proud to announce the Johns Hopkins Medicine Brady Urological Institute Residency Class of 2030! Congratulations and welcome to the team!! #urologymatch2025 #MatchDay
Our paper on IO combinations in metastatic translocation RCC is now online. Great collaborative work and addition to treatment outcomes in this rare entity. journals.lww.com/immunotherapy-… nirm Sumanta K. Pal, MD, FASCO Ritesh Kotecha Matthew Zibelman
Inspiring work from mentors David Braun Toni Choueiri, MD out nature developing amd testing a personalized neoantigen vaccine in high-risk #ccRCC Towards better outcomes for patients with kidney cancer
Glad to share our study from my lab led by Chengheng Liao (also co-corres) on establishing BBOX1 tumor suppressor signaling in kidney cancer Nature Communications rdcu.be/d9vkd , special thanks to Jeremy Simon Malladi Lab - UTSW Payal Kapur James Brugarolas and Deberardinis lab!
Congrats Roy Elias & team on taking this insightful work to the finish line! Thanks AACR for highlighting. Special thanks to the Hagaman research fund The Johns Hopkins Brady Urological Institute to make this all possible, generously allocated by Alan Partin, to whom we dedicate this work.
We agree with Elshad Hasanov, MD, PhD, new #kidneycancer research is the only path to achieving better understanding, care, and cures for patients 🧡 Proud to support him and researchers like YOU! Applications for KCA research grants due in ONE WEEK, submit today! kidneycancer.org/grants/
Congratulations James Brugarolas on your election to the Association of American Physicians. Great news for you, KidneyCancerProgram, and @UTSWCancer.
Congratulations to our one of a kind #AI #kidneycancer KidneyCancerProgram UTSW Computational Biology team with David Hein, Alana Christie, Bing Xie,Joseph Vento, MD, MS Andrew Jamieson Payal Kapur on npj Digital Medicine #LLM paper rdcu.be/enlxw
📢The KCA & UT Southwestern Medical Center invite researchers to participate in the *FIRST* RCC Animal Model Workshop this Sept 11-13! ‼️Apply by June 30, space limited‼️ Join us to drive research and accelerate therapeutics from lab to clinic. Email Salvatore La Rosa: [email protected]
I'm excited to speak at the Kidney Cancer Association's upcoming Virtual Patient Symposium on September 6! Join other kidney cancer patients and caregivers for a day of learning. Register here:kidneycancer.org/event/virtual-…. Kidney Cancer KidneyCancerProgram UTSW Simmons Cancer Center UTSW Department of Pathology